| Effects of fecal microbiota transplantation with oral capsules in obese patients JR Allegretti, Z Kassam, BH Mullish, A Chiang, M Carrellas, J Hurtado, ... Clinical Gastroenterology and Hepatology 18 (4), 855-863. e2, 2020 | 230 | 2020 |
| Combined endoscopic and oral fecal microbiota transplantation in patients with antibiotic-dependent pouchitis: low clinical efficacy due to low donor microbial engraftment H Herfarth, EL Barnes, MD Long, KL Isaacs, T Leith, M Silverstein, ... Inflammatory Intestinal Diseases 4 (1), 1-6, 2019 | 64 | 2019 |
| Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection JR Allegretti, CR Kelly, A Grinspan, BH Mullish, J Hurtado, M Carrellas, ... Inflammatory bowel diseases 27 (9), 1371-1378, 2021 | 44 | 2021 |
| Environmental microbiome engineering for the mitigation of climate change MR Silverstein, D Segrè, JM Bhatnagar Global Change Biology, 2023 | 16 | 2023 |
| Natural and anthropogenic carbon input affect microbial activity in salt marsh sediment ES Frates, RL Spietz, MR Silverstein, P Girguis, R Hatzenpichler, ... Frontiers in Microbiology 14, 1235906, 2023 | 2 | 2023 |
| Mo1954 ANAEROBIC FECAL MICROBIOTA TRANSPLANTATION PREPARATIONS ARE NOT NECESSARY FOR TREATMENT SUCCESSFUL ENGRAFTMENT MICROBIAL IN RECURRENT C. DIFFICILE INFECTION. G Mendolia, Z Kassam, EL McClure, HS Bi, N Chu, E Alm, Y Geradin, ... Gastroenterology 158 (6), S-991-S-992, 2020 | 2 | 2020 |
| 121 ulcerative colitis patients acheive more robust engraftment compared to patients with Crohn's disease after fecal microbiota transplantation for the treatment of recurrent … JR Allegretti, J Hurtado, M Carrellas, J Marcus, S Nemes, J Marchesi, ... Gastroenterology 158 (6), S-22, 2020 | 1 | 2020 |
| Metabolic complexity drives divergence in microbial communities M Silverstein, JM Bhatnagar, D Segrè bioRxiv, 2023 | | 2023 |
| Methods and compositions for treating disorders related to a gut dysbiosis Y Gerardin, S Timberlake, M Silverstein US Patent App. 16/813,100, 2020 | | 2020 |
Zain Kassam MD, MPHFinch TherapeuticsVerified email at mail.harvard.edu
